yeah Ford and Hanwa also looked like good offtakers too but then they disappeared from existence with no explanation...
its a non-binging MOU signed sheerly for the purpose of getting Stu Crow some free shares, Stu knew when he signed the MOU that there was no way LKE were gonna hit those dates
furthermore, who cares about who your offtaker is? the business is selling lithium, the mark of good business is selling to the highest bidder, if you sell to tesla or to some unknown company it makes no difference
lastly, the strategic investment is conditional at $1.20 per share, if you were an large company and a supplier you just made a deal with completely botched their own self set timeline by half a decade and it looked fairly clear that everything you were told in the lead up to signing the MOU was not accurate, why would you invest in them? especially at a 400% premium..
all that being said, its pointless giving a rosy eyed view at how successful a non binding offtake partner is when the real things you should be considering are massive CAPEX costs, no power on site until 2H 2027 with no solution chosen or costed yet, financing a project with such a low IRR using tech that has still at this point not been tested beyond a demo plant scale, dodgy directors doing dodgy things including getting caught submitting false loss reports at a previous company which he caused to go bankrupt by making a very bad business decisions, i know you wanna stay positive but all this needs to be figured out before you can start getting excited about potential partners
- Forums
- ASX - By Stock
- LKE towards TOP-5
yeah Ford and Hanwa also looked like good offtakers too but then...
-
- There are more pages in this discussion • 652 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LKE (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $63.40M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 3.8¢ | $230.1K | 5.879M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 4289511 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 160348 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 4189511 | 0.038 |
29 | 2802808 | 0.037 |
25 | 1850530 | 0.036 |
30 | 3837186 | 0.035 |
6 | 643852 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 160348 | 3 |
0.040 | 773696 | 12 |
0.041 | 662845 | 7 |
0.042 | 687425 | 8 |
0.043 | 478131 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LKE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online